Recombinant Human Cadherin-9 Fc Chimera Protein, CF Summary
Accession # Q9ULB4
|Formulation||Lyophilized from a 0.2 μm filtered solution in PBS.|
|Reconstitution||Reconstitute at 250 μg/mL in PBS.|
|Shipping||The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.|
|Stability & Storage:||
WhenRecombinant Human Cadherin 9 Fc Chimera is immobilized at 1 μg/mL, 100 μL/well,Recombinant Human Cadherin‑6/KCAD Fc Chimera (Catalog # 2715-CA) binds with an ED50 of 0.6-3.6μg/mL.
2 μg/lane of Recombinant Human Cadherin-9 was resolved with SDS-PAGE underreducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Bluestaining, showing bands at 92‑106 kDa and 180‑210 kDa, respectively.
Cadherin-9 (CDH9) is a member of the larger Cadherin superfamily of cell surface glycoproteins originally identified as proteins mediating cell-cell adhesion (1). In humans, there are more than 100 cadherin members divided into distinct families and numerous sub-families (1-3). Cadherins share a general structural architecture with an extracellular domain (ECD) containing 2 or more extracellular Ca2+ binding cadherin repeat (EC) domains, a single-pass transmembrane section, and a short cytoplasmic tail (1-3). Cadherins function by forming homophilic binding interactions through these EC domains to generate both trans and cis dimers (1-3). Human CDH9 is categorized as a classical cadherin, containing 5 EC domains, and the ECD shares 94% amino acid sequence identity with the ECD of both mouse and rat CDH9, respectively. Cadherins are found in diverse cell types and have been implicated as essential for the morphogenesis and homeostasis of multiple tissues and organs (1-3). Human CDH9 functions primarily in the central nervous system and is expressed in DG and CA3 neurons. Loss of CDH9 expression leads to defects in synapse formation and differentiation of specific neural circuits. (4). Additionally, disruption to CDH9 and CDH10 genes has been linked to autism spectrum disorders (5, 6). CDH9 expression has been identified in human kidney, and it has been used as a cell surface marker for fibroblasts (7). Recently, CDH9 has been reported as a potential suppressor of cancer metastasis (8).
- Gumbiner, B.M. (2005) Nat. Rev. Mol. Cell Biol. 6:622.
- Hirano S and Takeichi M. (2012) Physiol Rev. Apr; 92(2):597.
- Nollet et al. (2000) J Mol Biol. Jun. 9; 299(3):551.
- Williams ME et al. (2011) Neuron. Aug. 25; 71(4):640.
- Wang K. et al. (2009) Nature 459, 528.
- Inoue YU and, Inoue T. (2016) Sci Rep. 6:31227.
- Thedieck, C. et al. (2007) PLoS One. 2(8):e657.
- Yan G. et al. (2017) Scientific Reports volume 7, 10023.
No product specific FAQs exist for this product, however you mayView all Proteins and Enzyme FAQs
Reviews for Recombinant Human Cadherin-9 Fc Chimera Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human Cadherin-9 Fc Chimera Protein, CF and earn rewards!
Have you used Recombinant Human Cadherin-9 Fc Chimera Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image